Almut Lütge

Almut Lütge

Auto-generated profile, based on publicly available information

Almut Lütge

University of Zürich

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Nature Cancer
Verified
Journal Article
Closed access
PDF file
JLJunyan Lu
Junyan Lu
ECEster Cannizzaro
Ester Cannizzaro
FMFabienne Meier-Abt
Fabienne Meier-Abt
SSSebastian Scheinost
Sebastian Scheinost
PBPeter-Martin Bruch
Peter-Martin Bruch
WHWolfgang Huber
Wolfgang Huber

23 March 2021 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
ALAlmut Lütge
Almut Lütge
JZJoanna Zyprych-Walczak
Joanna Zyprych-Walczak
UKUrszula Brykczynska Kunzmann
Urszula Brykczynska Kunzmann
HCHelena L Crowell
Helena L Crowell
DCDaniela Calini
Daniela Calini
MRMark D Robinson
Mark D Robinson
A key challenge in single-cell RNA-sequencing (scRNA-seq) data analysis is batch effects that can obscure the biological signal of interest. Although there are various tools and methods to correct for batch effects, their performance can vary. Therefore, it is important to understand how batch effects manifest to adjust for them. Here, we systematically explore batch effects across various scRNA-seq datasets according to magnitude, cell type specificity, and complexity. We developed a cell-specific mixing score (cms) that quantifies mixing of cells from multiple batches. By considering distance distributions, the score is able to detect local batch bias as well as differentiate between unbalanced batches and systematic differences between cells of the same cell type. We compare metrics in scRNA-seq data using real and synthetic datasets and whereas these metrics target the same question and are used interchangeably, we find differences in scalability, sensitivity, and ability to handle differentially abundant cell types. We find that cell-specific metrics outperform cell type–specific and global metrics and recommend them for both method benchmarks and batch exploration.

4 November 2025 in Journal of Experimental Medicine
Verified
Journal Article
Open access
ABAline Bauer
Aline Bauer
LZLito Zambounis
Lito Zambounis
IKIoannis Kritikos
Ioannis Kritikos
ALAlmut Lütge
Almut Lütge
ASAmélie Sabine
Amélie Sabine
CHCornelia Halin
Cornelia Halin
Afferent lymphatic vessels (LVs) are present in most vascularized tissues and exert important immune and drainage functions, yet human afferent LVs remain poorly studied. Performing single-cell RNA sequencing of lymphatic endothelial cells (LECs) from human skin and subcutaneous adipose tissue, we identified various LEC subsets, including two valve LEC populations located on the upstream and downstream sides of the valve leaflets. The cell adhesion molecule CD24 emerged as a specific marker of upper valve leaflet LECs in human skin and contributed to lymphatic valve development in murine mesentery. Three-dimensional imaging further revealed several unique features of the human dermal lymphatic network, including a high proportion of LYVE-1+ pre-collecting vessels containing intraluminal valves, virtually no collectors, and absence of lymphatic muscle cell coverage. Moreover, LECs in blind-ended capillaries and around valves in pre-collectors displayed mixed junctional and morphological phenotypes. These findings reveal key differences between human and murine dermal afferent lymphatics and provide a deeper understanding of human lymphatic-related (patho)physiological processes.

23 September 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
ASAnthony Sonrel
Anthony Sonrel
ALAlmut Luetge
Almut Luetge
CSCharlotte Soneson
Charlotte Soneson
IMIzaskun Mallona
Izaskun Mallona
PGPierre-Luc Germain
Pierre-Luc Germain
MRMark D. Robinson
Mark D. Robinson
Computational methods represent the lifeblood of modern molecular biology. Benchmarking is important for all methods, but with a focus here on computational methods, benchmarking is critical to dissect important steps of analysis pipelines, formally assess performance across common situations as well as edge cases, and ultimately guide users on what tools to use. Benchmarking can also be important for community building and advancing methods in a principled way. We conducted a meta-analysis of recent single-cell benchmarks to summarize the scope, extensibility, neutrality, as well as technical features and whether best practices in open data and reproducible research were followed. The results highlight that while benchmarks often make code available and are in principle reproducible, they remain difficult to extend, for example, as new methods and new ways to assess methods emerge. In addition, embracing containerization and workflow systems would enhance reusability of intermediate benchmarking results, thus also driving wider adoption.

16 April 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
ALAlmut Lütge
Almut Lütge
JLJunyan Lu
Junyan Lu
JHJennifer Hüllein
Jennifer Hüllein
TWTatjana Walther
Tatjana Walther
LSLeopold Sellner
Leopold Sellner
TZThorsten Zenz
Thorsten Zenz
Despite the extensive catalogue of recurrent mutations in chronic lymphocytic leukaemia (CLL), the diverse molecular driving events and the resulting range of disease phenotypes remain incompletely understood. To study the molecular heterogeneity of CLL, we performed RNA-sequencing on 184 CLL patient samples. Unsupervised analysis revealed two major independent axes of gene expression variation: the first one aligned with the mutational status of the immunoglobulin heavy variable (IGHV) genes, and concomitantly, with the three-group stratification of CLL by global DNA methylation pattern, and affected biological functions including B- and T-cell receptor signaling. The second one aligned with trisomy 12 status and affected chemokine signaling. Furthermore, we searched for differentially expressed genes associated with gene mutations and copy-number aberrations and detected strong signatures for TP53, BRAF and SF3B1 , as well as for del(11)(q22.3), del(17)(p13) and del(13)(q14) beyond the dosage effect. We discovered strong non-additive effects (i.e., genetic interactions, or epistasis) of IGHV mutation status and trisomy 12 on multiple phenotypes, including the expression of 893 genes. Multiple types of epistasis were observed, including synergy, buffering, suppression and inversion. Our study reveals previously underappreciated gene expression signatures for (epi)genomic variants in CLL and the presence of epistasis between them. The findings will serve as a reference for a functional resolution of CLL molecular heterogeneity.

11 December 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
ALAlmut Luetge
Almut Luetge
JZJoanna Zyprych-Walczak
Joanna Zyprych-Walczak
UKUrszula Brykczynska Kunzmann
Urszula Brykczynska Kunzmann
HCHelena L Crowell
Helena L Crowell
DCDaniela Calini
Daniela Calini
MRMark D Robinson
Mark D Robinson
A key challenge in single cell RNA-sequencing (scRNA-seq) data analysis are dataset- and batch-specific differences that can obscure the biological signal of interest. While there are various tools and methods to perform data integration and correct for batch effects, their performance can vary between datasets and according to the nature of the bias. Therefore, it is important to understand how batch effects manifest in order to adjust for them in a reliable way. Here, we systematically explore batch effects in a variety of scRNA-seq datasets according to magnitude, cell type specificity and complexity. We developed a cell-specific mixing score ( cms ) that quantifies how well cells from multiple batches are mixed. By considering distance distributions (in a lower dimensional space), the score is able to detect local batch bias and differentiate between unbalanced batches (i.e., when one cell type is more abundant in a batch) and systematic differences between cells of the same cell type. We implemented cms and related metrics to detect batch effects or measure structure preservation in the CellMixS R/Bioconductor package. We systematically compare different metrics that have been proposed to quantify batch effects or bias in scRNA-seq data using real datasets with known batch effects and synthetic data that mimic various real data scenarios. While these metrics target the same question and are used interchangeably, we find differences in inter- and intra-dataset scalability, sensitivity and in a metric’s ability to handle batch effects with differentially abundant cell types. We find that cell-specific metrics outperform cell type-specific and global metrics and recommend them for both method benchmarks and batch exploration.